Clinical trial

Trial Evaluating Devil's Claw for the Treatment of Hip and Knee Osteoarthritis

NCT00295490 · University of Southampton, Other · Terminated

Key facts

NCT number NCT00295490
Title Trial Evaluating Devil's Claw for the Treatment of Hip and Knee Osteoarthritis
Official title A Randomized, Double-blind, Placebo-controlled, Dose-ranging Two- Centre Study to Evaluate the Efficacy and Safety of Devil's Claw in the Treatment of Knee and Hip Osteoarthritis
Lead sponsor University of Southampton, Other
Collaborators Pascoe Pharmazeutische Praeparate GmbH Industry
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Osteoarthritis, Knee, Hip
Intervention type Drug
Interventions Devil Claw, Placebo
Enrollment 67
Start date Dec 1, 2004
Primary completion Nov 1, 2007
Completion Jun 1, 2008
First posted Feb 23, 2006
Last update posted Sep 12, 2011
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies